Lista de obras -

Acute polyradiculopathies in HIV-infected patients ⬇️

artículo científico publicado el 1 de agosto de 1997

Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.

artículo científico publicado en 2016

CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment

artículo científico publicado en 2019

Candidal Meningitis in HIV‐Infected Patients: Analysis of 14 Cases ⬇️

artículo científico publicado el 1 de septiembre de 1997

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

artículo científico publicado en 2014

Cerebral abscess in an immunosuppressed patient

artículo científico publicado en 2005

Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients

artículo científico publicado en 2016

Consensus statement: recommendations for the management of metabolic bone disease in human immunodeficiency virus patients

artículo científico publicado en 2013

Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era ⬇️

artículo científico publicado el 16 de agosto de 2013

Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy

artículo científico publicado en 2015

Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening

artículo científico publicado en 2016

Discontinuation of Secondary Prophylaxis in Patients with Cytomegalovirus Retinitis Who Have Responded to Highly Active Antiretroviral Therapy

artículo científico publicado en 2001

Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection.

artículo científico publicado en 2018

Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting

scientific article published on 01 April 2019

Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection

artículo científico publicado en 2015

Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients

artículo científico publicado en 2014

Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study

artículo científico publicado en 2020

Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients

artículo científico publicado en 2014

Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity

artículo científico publicado en 2014

Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure

artículo científico publicado en 2001

Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine

scientific article published on 19 July 2019

Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV

artículo científico publicado en 2020

High Cytomegalovirus Antigenemia Levels and Cytomegalovirus Syndrome in Patients With AIDS ⬇️

artículo científico publicado el 1 de diciembre de 1997

High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

artículo científico publicado en 2014

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

artículo científico publicado en 2020

Impact of a structured HIV testing program in a hospital emergency department and a primary care center

artículo científico publicado en 2019

Improved Outcome of Cytomegalovirus Retinitis in AIDS Patients After Introduction of Protease Inhibitors ⬇️

artículo científico publicado el 1 de octubre de 1998

Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

artículo científico publicado en 2016

Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age

artículo científico publicado en 2018

Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected

artículo científico publicado en 2011

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

scientific article published on 25 November 2019

Lipid-Lowering Effect and Efficacy After Switching to Etravirine in HIV-Infected Patients With Intolerance to Suppressive HAART ⬇️

artículo científico publicado el 1 de enero de 2013

Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis

artículo científico publicado en 2015

Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir

artículo científico publicado en 2019

Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

scientific article published on 05 March 2020

Missing Scheduled Visits in the Outpatient Clinic as a Marker of Short-Term Admissions and Death ⬇️

artículo científico publicado el 1 de septiembre de 2012

Mycobacterial liver abscess in a patient with AIDS ⬇️

artículo científico publicado el 1 de marzo de 1998

Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene

artículo científico publicado en 2001

Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen ⬇️

artículo científico publicado el 4 de enero de 2002

Potential role of rilpivirine in simplification regimens

artículo científico publicado en 2013

Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir

artículo científico publicado en 2016

Prevalence of Primary Resistance Mutations to Integrase Inhibitors in Treatment-Naïve and -Experienced Patients Infected With B and Non-B HIV-1 Variants ⬇️

artículo científico publicado el 1 de enero de 2013

Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs.

artículo científico publicado en 2014

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

artículo científico publicado en 2004

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

artículo científico publicado en 2013

Redefining the HIV epidemic in Nigeria: from national to state level

artículo científico publicado en 2014

Risk Factors for Development of Tuberculosis after Isoniazid Chemoprophylaxis in Human Immunodeficiency Virus--Infected Patients ⬇️

artículo científico publicado el 19 de diciembre de 2001

Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

scientific article published on 11 March 2020

Safety and Pharmacokinetics of Lopinavir in HIV/HCV Coinfected Patients with Advanced Liver Disease ⬇️

artículo científico publicado el 1 de septiembre de 2011

Salmonella Lung Involvement in Patients With HIV Infection ⬇️

artículo científico publicado el 5 de noviembre de 1997

Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study.

artículo científico publicado en 2018

Solitary Pulmonary Nodule Due toLeishmaniain a Patient with AIDS ⬇️

artículo científico publicado el 1 de febrero de 1998

Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity

artículo científico publicado en 2018

Switching to dual antiretroviral regimens is associated with improvement or no changes in activation and inflammation markers in virologically suppressed HIV-1-infected patients: the TRILOBITHE pilot study

artículo científico publicado en 2019

The Spanish HIV BioBank: a model of cooperative HIV research

artículo científico publicado en 2009

The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens

artículo científico publicado en 2015

The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients ⬇️

artículo científico publicado el 5 de junio de 2013

The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score ⬇️

artículo científico publicado el 24 de abril de 2011

The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients

artículo científico publicado el 1 de septiembre de 2012

Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients.

artículo científico publicado en 2014

Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients

artículo científico publicado en 1999

Lista de obras de

Acute polyradiculopathies in HIV-infected patients ⬇️

Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.

CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment

Candidal Meningitis in HIV‐Infected Patients: Analysis of 14 Cases ⬇️

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

Cerebral abscess in an immunosuppressed patient

Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients

Consensus statement: recommendations for the management of metabolic bone disease in human immunodeficiency virus patients

Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era ⬇️

Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy

Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening

Discontinuation of Secondary Prophylaxis in Patients with Cytomegalovirus Retinitis Who Have Responded to Highly Active Antiretroviral Therapy

Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection.

Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting

Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection

Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients

Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study

Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients

Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity

Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure

Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine

Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV

High Cytomegalovirus Antigenemia Levels and Cytomegalovirus Syndrome in Patients With AIDS ⬇️

High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

Impact of a structured HIV testing program in a hospital emergency department and a primary care center

Improved Outcome of Cytomegalovirus Retinitis in AIDS Patients After Introduction of Protease Inhibitors ⬇️

Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age

Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

Lipid-Lowering Effect and Efficacy After Switching to Etravirine in HIV-Infected Patients With Intolerance to Suppressive HAART ⬇️

Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis

Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir

Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

Missing Scheduled Visits in the Outpatient Clinic as a Marker of Short-Term Admissions and Death ⬇️

Mycobacterial liver abscess in a patient with AIDS ⬇️

Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene

Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen ⬇️

Potential role of rilpivirine in simplification regimens

Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir

Prevalence of Primary Resistance Mutations to Integrase Inhibitors in Treatment-Naïve and -Experienced Patients Infected With B and Non-B HIV-1 Variants ⬇️

Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs.

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

Redefining the HIV epidemic in Nigeria: from national to state level

Risk Factors for Development of Tuberculosis after Isoniazid Chemoprophylaxis in Human Immunodeficiency Virus--Infected Patients ⬇️

Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

Safety and Pharmacokinetics of Lopinavir in HIV/HCV Coinfected Patients with Advanced Liver Disease ⬇️

Salmonella Lung Involvement in Patients With HIV Infection ⬇️

Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study.

Solitary Pulmonary Nodule Due toLeishmaniain a Patient with AIDS ⬇️

Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity

Switching to dual antiretroviral regimens is associated with improvement or no changes in activation and inflammation markers in virologically suppressed HIV-1-infected patients: the TRILOBITHE pilot study

The Spanish HIV BioBank: a model of cooperative HIV research

The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens

The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients ⬇️

The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score ⬇️

The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients

Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients.

Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients